Literature DB >> 11120855

Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling.

A Heinemann1, A Hartnell, V E Stubbs, K Murakami, D Soler, G LaRosa, P W Askenase, T J Williams, I Sabroe.   

Abstract

To investigate human basophil responses to chemokines, we have developed a sensitive assay that uses flow cytometry to measure leukocyte shape change as a marker of cell responsiveness. PBMC were isolated from the blood of volunteers. Basophils were identified as a single population of cells that stained positive for IL-3Ralpha (CDw123) and negative for HLA-DR, and their increase in forward scatter (as a result of cell shape change) in response to chemokines was measured. Shape change responses of basophils to chemokines were highly reproducible, with a rank order of potency: monocyte chemoattractant protein (MCP) 4 (peak at <1 nM) >/= eotaxin-2 = eotaxin-3 >/= eotaxin > MCP-1 = MCP-3 > macrophage-inflammatory protein-1alpha > RANTES = MCP-2 = IL-8. The CCR4-selective ligand macrophage-derived chemokine did not elicit a response at concentrations up to 10 nM. Blocking mAbs to CCR2 and CCR3 demonstrated that responses to higher concentrations (>10 nM) of MCP-1 were mediated by CCR3 rather than CCR2, whereas MCP-4 exhibited a biphasic response consistent with sequential activation of CCR3 at lower concentrations and CCR2 at 10 nM MCP-4 and above. In contrast, responses to MCP-3 were blocked only in the presence of both mAbs, but not after pretreatment with either anti-CCR2 or anti-CCR3 mAb alone. These patterns of receptor usage were different from those seen for eosinophils and monocytes. We suggest that cooperation between CCRs might be a mechanism for preferential recruitment of basophils, as occurs in tissue hypersensitivity responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120855     DOI: 10.4049/jimmunol.165.12.7224

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  The deleterious role of basophils in systemic lupus erythematosus.

Authors:  Christophe Pellefigues; Nicolas Charles
Journal:  Curr Opin Immunol       Date:  2013-10-24       Impact factor: 7.486

Review 2.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

3.  Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic.

Authors:  Andriana-C Kaliora; Maria-G Stathopoulou; John-K Triantafillidis; George-Vz Dedoussis; Nikolaos-K Andrikopoulos
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

4.  CCL24 Signaling in the Tumor Microenvironment.

Authors:  Sung-Jig Lim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor.

Authors:  Karen F Buckland; Timothy J Williams; Dolores M Conroy
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

6.  Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3.

Authors:  Sohee Kim; Melanie Prout; Hayley Ramshaw; Angel F Lopez; Graham LeGros; Booki Min
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

Review 7.  Autoantibodies in systemic lupus erythematosus.

Authors:  Stephen D Marks; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-12-23       Impact factor: 3.651

8.  The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives.

Authors:  Radhia Boumiza; Anne-Lise Debard; Guillaume Monneret
Journal:  Clin Mol Allergy       Date:  2005-06-30

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

10.  IL-25 and IL-33 induce Type 2 inflammation in basophils from subjects with allergic asthma.

Authors:  Brittany M Salter; John Paul Oliveria; Graeme Nusca; Steve G Smith; Damian Tworek; Patrick D Mitchell; Rick M Watson; Roma Sehmi; Gail M Gauvreau
Journal:  Respir Res       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.